Strategic Partnering

Merrion's patented GIPET® technology can provide new product profiles not available anywhere else.

Merrion's technology is endorsed through collaborations with pharmaceutical companies such as Novo Nordisk (oral insulin, oral GLP-1), Ferring Pharmaceuticals, Rebel Pharmaceuticals, Top Ten Pharma and others.

Merrion offers unique prescription pharmaceutical products to meet the key unmet needs of the pharmaceutical industry.

Long patent life
Oral forms of injectable only drugs
Oral forms of biopharmaceuticals
Large (10 - 50 fold) bioavailability improvements with excellent reproducibility
Improved efficacy
Improved safety, side effect and toxicity profile
Improved health economics
Improved patient QOL
New indications
Market expansion
Emerging market expansion

Merrion is seeking to advance the development of a range of unique new products by establishing further collaborations with pharmaceutical companies. If you are interested in discussing collaboration, please contact our Business Development Department at bd@merrionpharma.com